Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell of proximal tubule | 7 studies | 25% ± 8% | |
hepatocyte | 5 studies | 56% ± 17% | |
astrocyte | 4 studies | 26% ± 8% | |
adipocyte | 3 studies | 21% ± 1% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
liver | 3 studies | 33% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 4257.49 | 89 / 89 | 98% | 75.13 | 882 / 901 |
liver | 100% | 13231.52 | 226 / 226 | 97% | 102.56 | 395 / 406 |
esophagus | 99% | 404.23 | 1425 / 1445 | 95% | 14.85 | 174 / 183 |
intestine | 99% | 712.03 | 961 / 966 | 94% | 12.71 | 494 / 527 |
pancreas | 99% | 466.04 | 326 / 328 | 93% | 9.96 | 166 / 178 |
stomach | 99% | 591.13 | 355 / 359 | 92% | 11.50 | 264 / 286 |
bladder | 100% | 464.10 | 21 / 21 | 90% | 10.81 | 454 / 504 |
prostate | 99% | 404.89 | 242 / 245 | 90% | 14.86 | 450 / 502 |
thymus | 100% | 465.10 | 652 / 653 | 84% | 7.18 | 511 / 605 |
uterus | 95% | 255.01 | 162 / 170 | 88% | 12.34 | 402 / 459 |
skin | 99% | 456.72 | 1794 / 1809 | 83% | 9.29 | 392 / 472 |
lung | 86% | 308.33 | 499 / 578 | 95% | 14.22 | 1094 / 1155 |
breast | 100% | 581.48 | 459 / 459 | 80% | 7.92 | 889 / 1118 |
ovary | 92% | 209.24 | 165 / 180 | 86% | 8.98 | 371 / 430 |
brain | 92% | 285.20 | 2433 / 2642 | 63% | 4.10 | 443 / 705 |
adrenal gland | 96% | 368.65 | 248 / 258 | 50% | 4.53 | 116 / 230 |
adipose | 100% | 715.01 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 362.26 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 20.68 | 45 / 45 |
blood vessel | 96% | 259.22 | 1285 / 1335 | 0% | 0 | 0 / 0 |
heart | 93% | 622.21 | 803 / 861 | 0% | 0 | 0 / 0 |
muscle | 61% | 104.01 | 491 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 41% | 3.60 | 12 / 29 |
eye | 0% | 0 | 0 / 0 | 36% | 3.18 | 29 / 80 |
peripheral blood | 21% | 65.61 | 197 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006635 | Biological process | fatty acid beta-oxidation |
GO_0033540 | Biological process | fatty acid beta-oxidation using acyl-CoA oxidase |
GO_0005829 | Cellular component | cytosol |
GO_0005777 | Cellular component | peroxisome |
GO_0005782 | Cellular component | peroxisomal matrix |
GO_0003857 | Molecular function | 3-hydroxyacyl-CoA dehydrogenase activity |
GO_0070403 | Molecular function | NAD+ binding |
GO_0019899 | Molecular function | enzyme binding |
GO_0016863 | Molecular function | intramolecular oxidoreductase activity, transposing C=C bonds |
GO_0004300 | Molecular function | enoyl-CoA hydratase activity |
GO_0004165 | Molecular function | delta(3)-delta(2)-enoyl-CoA isomerase activity |
GO_0005515 | Molecular function | protein binding |
GO_0016509 | Molecular function | long-chain-3-hydroxyacyl-CoA dehydrogenase activity |
GO_0018812 | Molecular function | 3-hydroxyacyl-CoA dehydratase activity |
Gene name | EHHADH |
Protein name | Peroxisomal bifunctional enzyme (PBE) (PBFE) (L-bifunctional protein) (LBP) (Multifunctional enzyme 1) (MFE1) [Includes: Enoyl-CoA hydratase/3,2-trans-enoyl-CoA isomerase (EC 4.2.1.17) (EC 5.3.3.8); 3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.35)] Enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase Peroxisomal bifunctional enzyme (Multifunctional enzyme 1) |
Synonyms | ECHD |
Description | FUNCTION: Peroxisomal trifunctional enzyme possessing 2-enoyl-CoA hydratase, 3-hydroxyacyl-CoA dehydrogenase, and delta 3, delta 2-enoyl-CoA isomerase activities. Catalyzes two of the four reactions of the long chain fatty acids peroxisomal beta-oxidation pathway (By similarity). Can also use branched-chain fatty acids such as 2-methyl-2E-butenoyl-CoA as a substrate, which is hydrated into (2S,3S)-3-hydroxy-2-methylbutanoyl-CoA (By similarity). Optimal isomerase for 2,5 double bonds into 3,5 form isomerization in a range of enoyl-CoA species (Probable). Also able to isomerize both 3-cis and 3-trans double bonds into the 2-trans form in a range of enoyl-CoA species (By similarity). With HSD17B4, catalyzes the hydration of trans-2-enoyl-CoA and the dehydrogenation of 3-hydroxyacyl-CoA, but with opposite chiral specificity . Regulates the amount of medium-chain dicarboxylic fatty acids which are essential regulators of all fatty acid oxidation pathways (By similarity). Also involved in the degradation of long-chain dicarboxylic acids through peroxisomal beta-oxidation . . |
Accessions | A0PJI6 ENST00000440662.1 C9JJE0 ENST00000231887.8 [Q08426-1] Q08426 ENST00000456310.5 [Q08426-2] |